- Home
- NSIT vs ACLX Comparison
NSIT vs ACLX Comparison
Compare NSIT & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSIT
- ACLX
- Stock Information
- Founded
- NSIT 1988
- ACLX 2015
- Country
- NSIT United States
- ACLX United States
- Employees
- NSIT N/A
- ACLX N/A
- Industry
- NSIT EDP Services
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- NSIT Technology
- ACLX Health Care
- Exchange
- NSIT Nasdaq
- ACLX Nasdaq
- Market Cap
- NSIT 2.8B
- ACLX 4.4B
- IPO Year
- NSIT 1995
- ACLX 2022
- Fundamental
- Price
- NSIT $91.21
- ACLX $86.55
- Analyst Decision
- NSIT Buy
- ACLX Strong Buy
- Analyst Count
- NSIT 3
- ACLX 9
- Target Price
- NSIT $168.33
- ACLX $117.78
- AVG Volume (30 Days)
- NSIT 466.5K
- ACLX 416.8K
- Earning Date
- NSIT 10-30-2025
- ACLX 11-05-2025
- Dividend Yield
- NSIT N/A
- ACLX N/A
- EPS Growth
- NSIT N/A
- ACLX N/A
- EPS
- NSIT 4.21
- ACLX N/A
- Revenue
- NSIT $8,271,548,000.00
- ACLX $35,898,000.00
- Revenue This Year
- NSIT N/A
- ACLX N/A
- Revenue Next Year
- NSIT $3.42
- ACLX $220.95
- P/E Ratio
- NSIT $21.65
- ACLX N/A
- Revenue Growth
- NSIT N/A
- ACLX N/A
- 52 Week Low
- NSIT $89.50
- ACLX $47.86
- 52 Week High
- NSIT $181.92
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- NSIT 15.23
- ACLX 52.73
- Support Level
- NSIT $97.30
- ACLX $84.00
- Resistance Level
- NSIT $111.54
- ACLX $90.30
- Average True Range (ATR)
- NSIT 3.33
- ACLX 3.57
- MACD
- NSIT -1.09
- ACLX -0.31
- Stochastic Oscillator
- NSIT 7.92
- ACLX 42.53
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.